Key facts
- It has raised $2.5M across 1 recorded rounds; the latest was Later Stage VC (Series A) ($2.5M) in Apr 2019.
- Massive Bio has filed 1 Form D with the SEC, most recently May 2019 ($2.5M sold to 2 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Massive Bio
Create free account
No card required
Funding rounds
1 roundsApr 2019Later Stage VC (Series A)$2.5M▮
About Massive Bio
- Industry
- Other Healthcare Technology Systems
PA Mark — not yet priced
Massive Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Massive Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Massive Bio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.